Latest news with #LifeMD
Yahoo
8 hours ago
- Business
- Yahoo
LifeMD to Report Second Quarter 2025 Financial Results on August 5
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on August 5, 2025, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date: Tuesday, August 5th Time: 4:30 p.m. Eastern time Toll-Free Dial-In: 800-445-7795 International Dial-In: 785-424-1699 Conference ID: LIFEMD Live & Archived Webcast: Link About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit Investor ContactMarc Benathen, Chief Financial Officermarc@ Media Contact Jessica Friedeman, Chief Marketing Officerpress@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24-06-2025
- Business
- Yahoo
LifeMD, Inc. (NASDAQ:LFMD) Could Be Less Than A Year Away From Profitability
With the business potentially at an important milestone, we thought we'd take a closer look at LifeMD, Inc.'s () future prospects. LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. With the latest financial year loss of US$22m and a trailing-twelve-month loss of US$14m, the US$650m market-cap company alleviated its loss by moving closer towards its target of breakeven. Many investors are wondering about the rate at which LifeMD will turn a profit, with the big question being 'when will the company breakeven?' In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. LifeMD is bordering on breakeven, according to the 7 American Healthcare Services analysts. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$2.3m in 2025. The company is therefore projected to breakeven around 12 months from now or less. How fast will the company have to grow to reach the consensus forecasts that anticipate breakeven by 2025? Working backwards from analyst estimates, it turns out that they expect the company to grow 105% year-on-year, on average, which signals high confidence from analysts. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict. Given this is a high-level overview, we won't go into details of LifeMD's upcoming projects, though, bear in mind that by and large healthcare tech companies, depending on the stage of product development, have irregular periods of cash flow. So, a high growth rate is not out of the ordinary, particularly when a company is in a period of investment. See our latest analysis for LifeMD Before we wrap up, there's one issue worth mentioning. LifeMD currently has negative equity on its balance sheet. This can sometimes arise from accounting methods used to deal with accumulated losses from prior years, which are viewed as liabilities carried forward until it cancels out in the future. Oftentimes, losses exist only on paper but other times, it can be a red flag. There are too many aspects of LifeMD to cover in one brief article, but the key fundamentals for the company can all be found in one place – LifeMD's company page on Simply Wall St. We've also compiled a list of relevant aspects you should look at: Valuation: What is LifeMD worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether LifeMD is currently mispriced by the market. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on LifeMD's board and the CEO's background. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Health Line
24-06-2025
- Health
- Health Line
LifeMD Review: Membership, Pricing, and Plans
Key takeaways LifeMD is a membership-based telehealth platform. It's popular for its Weight Management Program with GLP-1 access. LifeMD Plus membership costs $19 monthly, while its Weight Management Program starts from $79 monthly. LifeMD accepts Medicare and some insurance plans but has limited coverage. LifeMD Pros and Cons Pros 24/7 urgent and primary care same-day prescriptions local pharmacy collection lab testing options lower cost appointments and medications member-only offers no insurance required Cons requires a monthly subscription limited insurance coverage online only unsuitable for emergencies LifeMD Weight Management Program LifeMD's leading service is its Weight Management Program. It allows members to access the following Food and Drug Administration (FDA)-approved GLP-1 medications: On signup, you complete a questionnaire on your health and medical history. Within a week, you are matched with a healthcare professional who will assess your submission and determine if Wegovy is suitable for you. If you are eligible, you'll undergo lab tests, including a metabolic test. Your provider will then review the results to create a personalized weight loss plan and write a GLP-1 prescription. As a member of the Weight Management Program, you will receive support from a medical professional and can undergo regular metabolic testing. The LifeMD Weight Management Program starts from $79 monthly. The cost varies depending on the type of medication. If members don't experience at least a 10% weight reduction after 1 year, they can receive a refund. LifeMD Plus services LifeMD Plus costs $19 monthly and provides access to general healthcare services, including 24/7 primary and urgent care via video visits or chat messaging. It also provides same-day prescriptions. With LifeMD Plus, members can access services for many health concerns, such as: urinary tract infections (UTIs) acne erectile dysfunction (ED) premature ejaculation sexually transmitted infections (STIs) insomnia and sleep disturbances allergies and hayfever arthritis contraception migraine LifeMD also offers routine and specialty lab testing with partner companies Quest Diagnostics or LabCorp. These tests may come as at-home kits or require an in-person visit to a lab. Results are viewable online. LifeMD pricing and coverage LifeMD is a membership-based platform, meaning only paying members can access LifeMD services. The monthly membership costs are: LifeMD Plus: $19 monthly. Weight Management Program (GLP-1 injections): from $79 monthly Weight Management Program (oral medication): $129 monthly Virtual consultations, prescriptions, and lab work may come at an additional cost and can vary depending on insurance coverage. The costs without insurance are: video appointment: $50 message-based consults: $20 lab testing: variable The LifeMD Weight Management Program is not eligible for insurance coverage or Medicare. Frequently asked questions about LifeMD Is LifeMD a real company? Yes, LifeMD is a real and legitimate company. It provides various telehealth services, including same-day medication prescriptions, general and urgent healthcare consultations via video or chat, and health testing. Its most popular service is its Weight Management Program with GLP-1 medications. Yes, LifeMD is a real and legitimate company. It provides various telehealth services, including same-day medication prescriptions, general and urgent healthcare consultations via video or chat, and health testing. Its most popular service is its Weight Management Program with GLP-1 medications. Does LifeMD cost include medication? LifeMD prescriptions are an additional cost to its membership and offers low cost prescription options. LifeMD does accept some insurance plans for medication, though this varies depending on the provider and medication. The LifeMD Weight Management Program does not include the cost of medication. This is an additional payment and is not covered by insurance. LifeMD prescriptions are an additional cost to its membership and offers low cost prescription options. LifeMD does accept some insurance plans for medication, though this varies depending on the provider and medication. The LifeMD Weight Management Program does not include the cost of medication. This is an additional payment and is not covered by insurance.
Globe and Mail
19-06-2025
- Business
- Globe and Mail
Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), LifeMD (LFMD) and Novo Nordisk (NVO)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zai Lab (ZLAB – Research Report), LifeMD (LFMD – Research Report) and Novo Nordisk (NVO – Research Report). Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Zai Lab (ZLAB) Bank of America Securities analyst David Li maintained a Hold rating on Zai Lab today and set a price target of $38.20. The company's shares closed last Tuesday at $37.22, close to its 52-week high of $39.77. Li has an average return of 17.5% when recommending Zai Lab. ;'> According to Li is ranked #6632 out of 9628 analysts. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Zai Lab with a $53.04 average price target. LifeMD (LFMD) In a report released today, David Larsen from BTIG maintained a Buy rating on LifeMD, with a price target of $18.00. The company's shares closed last Tuesday at $13.58. According to Larsen is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -10.1% and a 29.7% success rate. Larsen covers the Healthcare sector, focusing on stocks such as Definitive Healthcare Corp, P3 Health Partners, and Oncology Institute. ;'> LifeMD has an analyst consensus of Strong Buy, with a price target consensus of $12.00. Novo Nordisk (NVO) TD Cowen analyst Michael Nedelcovych maintained a Buy rating on Novo Nordisk today and set a price target of $105.00. The company's shares closed last Tuesday at $74.34, close to its 52-week low of $69.18. According to Nedelcovych is ranked 0 out of 5 stars with an average return of -12.6% and a 33.3% success rate. Nedelcovych covers the Healthcare sector, focusing on stocks such as Takeda Pharmaceutical Company, Bausch Health Companies, and Molecular Partners AG. ;'> Novo Nordisk has an analyst consensus of Hold, with a price target consensus of $92.71.
Yahoo
09-06-2025
- Health
- Yahoo
Health-E Commerce® expands telehealth offerings with LifeMD™ to provide sleep treatments via FSA Store® and HSA Store®
New collaboration delivers 50% off prescription sleep support for new customers who are struggling with insomnia and sleep disruption DALLAS, June 9, 2025 /PRNewswire/ -- Health-E Commerce, the parent brand of FSA Store and HSA Store, the first and leading online stores dedicated to selling only FSA- and HSA-eligible products and services, announced today that it has expanded its telehealth collaboration with LifeMD™, a leader in virtual care. This latest initiative gives FSA and HSA users affordable, convenient access to FDA-approved prescription sleep treatments at a time when better sleep care is urgently needed. According to the CDC, insufficient sleep is linked to higher risks of obesity, diabetes, heart disease, and depression, which means expanded access to treatment is not just beneficial, it's essential. The arrangement allows new customers who shop at FSA Store or HSA Store to receive 50% off prescription sleep medications from LifeMD, with no in-person appointments required. Following a free virtual consultation, approved patients can have non-addictive, physician-prescribed treatments discreetly delivered to their door, making it easier than ever to address sleep concerns with clinically backed solutions. "The connection between sleep and our overall physical and mental health is undeniable, and poor sleep can even impact our productivity at work and our overall quality of life," said Keri Kaiser, chief revenue officer for Health-E Commerce. "The expansion of our telehealth collaboration with LifeMD gives consumers more options for diagnosing and treating sleep disorders and improving sleep health, while saving money by using tax-free FSA- and HSA-eligible services. We're proud to simplify access to care for millions of Americans and to maximize their healthcare dollars." Many individuals who experience poor sleep rely on over-the-counter remedies that may not be effective for persistent insomnia or sleep disruptions. Fortunately, LifeMD's prescription sleep solutions are designed to address the root causes of poor sleep with medications that target sleep onset, duration, and quality, including Ramelteon, Doxepin, and Trazodone. Eligibility for prescription treatments is determined by a licensed LifeMD physician and backed by LifeMD's 4.9-star patient satisfaction rating. "We're proud to expand our telehealth collaboration with Health-E Commerce to give individuals and families who are enrolled in FSAs and HSAs access to clinical support to improve sleep health and their overall quality of life," said Nicholas Alvarez, co-founder and chief acquisition & growth officer at LifeMD. "Everyone deserves access to quality medical care that is convenient and affordable, and by collaborating with FSA Store and HSA Store, we are able to effectively extend the reach of our services to individuals and families across the country." LifeMD's sleep solutions are now available at and alongside other telehealth services for home sleep apnea testing, CPAP devices and supplies, CPAP alternatives, and more. This launch reinforces Health-E Commerce's mission to make tax-free healthcare dollars work harder for the more than 70 million Americans enrolled in pre-tax health accounts. To learn more or access eligible sleep health services and products, visit or About Health-E CommerceHealth-E Commerce is the parent brand to FSA Store and HSA Store, online stores that serve the 70+ million consumers enrolled in pre-tax health and wellness accounts. The company also created Caring Mill®, a popular private-label line of health products through which a portion of every purchase is donated to the Children's Health Fund. Since 2010, the Health-E Commerce brands have led the direct-to-consumer e-commerce market for exclusively pre-tax health and wellness benefits. Health-E Commerce plays an essential role in expanding eligibility for important new product and telehealth categories within the list of eligible medical expenses. About LifeMDLifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. The Company leverages a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit View original content to download multimedia: SOURCE Health-E Commerce Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
